Submissions

Login or Register to make a submission.

Author Guidelines

Instruction for the submission of the manuscript

BJPain journal has specific instructions and guidelines for submitting manuscript. Those instructions and guidelines are readily available on the submission service site (www.bjpain.org).Please read and review them carefully before making any submission. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected or will be a matter of re-submission.

Submission checklist

Before final submission please check that your manuscript has following documents:

  1. Cover letter.
  2. Separate Title page containing type of work(eg. original contribution, case report etc.), title of the manuscript, name of the contributors (up to seven), affiliation/ current work place, and email address of all authors, corresponding author details including cell phone number.
  3. Main text of the manuscript where no signs and information of the author or author team are available.
  4. Tables and figures must be embedded in the text. For example: when you write the description of the table 1/figure 1, you must keep the table/figures close proximity to the description.
  5. Ethical statement embedded in the methods and declaration section.
  6. Supplementary file (if any).
  7. Consort statement or other relevant statement (if applicable).
  8. Authorship agreement form (Available in BJPain website).
  9. References in right form.
  10. Language editing certificate (if applicable).
  11. Statistical proficiency certificate (if applicable).

If the author have all necessary documents in hand, the author can submit the manuscript by following the submission link: https://bjpain.org/bjpan/submission. Manuscripts must be submitted via the account of the Corresponding Author. One must register the site before submission with providing necessary details. Before submission of the manuscript, the author must be sure that he/she followed the detailed author instructions and submission guideline (URL link for submission guideline).Please upload the file written in Microsoft word, DOC, DOCX, PDF or any other format are not allowed and will be subjected to resubmission.

Instructions for preparing your manuscript:

Quick Look:

  • Use double line spacing
  • Use “Time New Roman” font Font size will be 12
  • Standard page formatting (left 1.5-inch space, upper, lower and right side of the page-1 inch space)
  • Include line numbers in the left by using Microsoft continuous line options
  • All page must have page number and page number in right upper corner
  • Use SI units: Please ensure that all special characters used are embedded in the text
  • Do not use page breaks in your manuscript
  • Do not use the automatic formatting features of your word processor such as footnotes, headers, footers, boxes etc.
  • Please remove any hidden text
  • Statistical analyses must explain the methods used
  • Drugs should be given their approved generic name.
  • Acronyms should be used sparingly and fully explained when first used.
  • All abbreviation should be fully stated in the text where it first appears and abbreviation in parenthesis.
  • Subsequently the abbreviation only may be used.

File format

The following word processor file formats are acceptable for the main manuscript document: Microsoft word (DOC, DOCX) and Rich text format (RTF).

NB: Please note that for editorial processing and production, editable files are required. If your manuscript contains any non-editable files (such as PDFs), it will be a subject of re-submission. In that case, you may need to resubmit your manuscript again after necessary corrections.

Style and language

The language of the article must be in English with sufficient clarity, readability and understandability of the editorial team as well as reviewers. Text should be presented in English

(either American or British) and prohibited to use a mixture of these. Manuscripts with inclusive language with good clarity often get preference if all other preconditions are fulfilled. The authors who are not native speakers of English are advised to be pre-reviewed by colleagues with English fluency or they can take help from professional language editing service from any colleague who is native speaker in English. The assistance shall be acknowledged in declaration section. Please note that the use of a language editing service is not a requirement for publication in this journal and does not imply or guarantee that the article will be selected for peer review or accepted. More importantly we do not suggest any particular agency for this language editing services.

Data sharing

BJPain Journal encourages the author or author group to share data that supports your research publication where appropriate. However, data set sharing is not mandatory but the corresponding author must have the data set ready at hand during submission. If necessary, the editorial board may seek the data set and will use to recheck the statistics. In no cases, data file will be shared in public without prior consent of the author.

Details of the preparing the manuscript

Arrange the manuscript in this order:

Cover letter

Use the cover letter to explain why your paper should be published in The BJPain rather than elsewhere. What are the important findings of the research work and what would be the future implication of the study the corresponding author must declare if any competing interest present.

Title page

The title page should include the followinginformation:

  • Manuscript Title: title should be brief, succinct and not too large.
  • Author names and affiliation. Name of authors should be written in full, first name followed by surname. Academic degrees may be listed for each author (choose highest degrees). A superscript number should be placed after each name to refer to the respective affiliation that must be listed below. Provide the full postal address, contact number, and email address for each author.
  • Corresponding author information. Please ensure that any changes to the contact details of the corresponding author must immediately be notified to the Editorial Office
  • Authors role must be present in title page and not to be presented in declaration section.

Abstract

The abstract must be structured (Background, Methods, Results and Conclusion), and the word limit is determined by the relevant article type.

Trial registration

If your article reports the results of a health care intervention on human participants, it must be registered in an appropriate registry and the registration number and date of registration should be stated in the last part of the abstract. If it was not registered prospectively (before enrollment of the first participant), you should include the words 'retrospectively registered'. Trial registration number or statement must be present in the methods section.

Keywords

At the end of the abstract, please include an alphabetical list of 5 (maximum) keywords and subjects for indexing. Choose the keywords carefully as these will be used for subsequent retrieval.

Main text

Main text should be formed according to the article type. However, an original report must contain following points: Introduction, Methods, Results, Discussion, Limitations of the study, Conclusion and Future implications of the study.

  • The introduction should explain the rationale behind the current study, placing the research topic and study within the context of the current research landscape. Authors should summarize and cite previous research relevant to the current study and highlight the gap in knowledge being filled by the present research. The final paragraph should clearly state the primary and, if applicable, secondary aims of the study. Any variables, used in the study, which do not have universal definition should be operationalized. The introduction to a paper should not exceed more than 400-500 words and is double-spaced.
  • The ‘Methods’ section (or sections: e.g. Participants, Materials, Procedure) should contain a clear and concise description and when needed, justification of the conditions and procedures of the study as well as analytical tools or methodology used. All excluded observations, independent variables/ manipulations and dependent variables/ measures must be reported and authors must explain how the sample size was determined. This section should not contain more than 500-700 words. In case of clinical trials either prospectively registered or retrospectively registered must be declared in methods section.
  • The ‘Results’ section should present the collected data and analysis. Results for all measures should be reported in a concise, straightforward manner, using tables or figures when appropriate. Duplication of information that is presented in tables or figures should be minimal in the text and all results should be reported in the text rather than figure captions. Authors should be mindful to exclude interpretation and discussion of the findings or any details related to methodology from this section. The ‘Results’ section should not contain more than 300-400 words.
  • The purpose of the ‘Discussion’ section is to interpret and describe the significance of your findings in light of what was already known about the research problem being investigated and to explain any new understanding or fresh insights about the problem after you have taken the findings into consideration. The discussion will always connect to the introduction by way of the research questions or hypotheses you posed and the literature you reviewed but it does not simply repeat or rearrange the introduction. The discussion should always explain how your study has moved the reader's understanding of the research problem forward from where you left them at the end of the introduction. Avoid un-qualified statements and conclusions which are not supported by the data. This section should not contain more than 300-400 words.
  • Limitations:Limitations should be brief and must have an explanation how the author have tried to mitigate the limitations.
  • Conclusion:A conclusion is not merely a summary of the main topics covered or a re-statement of your research problem but a synthesis of key points and, if applicable, where you recommend new areas for future research.
  • Future implications: In this section, the author must state that why the study isimportant and what will be the implications of this study findings.

Declaration section

The declaration section should contain funding statement, ethical approval statement, acknowledgments, conflict of interest statement, and other relevant statement according to the nature of the manuscript. The chronology to write declaration section following points should be used using this order:

References

A total number of references more than 50 are discouraged and a number of references depends on article type as mentioned earlier. Number of references consecutively in order of their appearance in the text. Identify references in text, tables and legends by Arabic numerals as superscripts. References cited only in tables or in legends to figures should be numbered in accordance with the sequence established in the text. Use the style of the examples shown below, which are based on the formats used by the U. S. National Library of Medicine and also available in here: https://www.nlm.nih.gov/bsd/uniform_require ments.html. Try to avoid using abstracts as references. “unpublished observations” and “personal communications” may not be used as references. Although references to written, not oral, communications may be inserted (within parenthesis marks) in the text, include among the reference papers accepted but not yet published, designate the journal and add “in press” (within parenthesis marks). Information from manuscripts submitted but not yet accepted should be cited in the text as unpublished observations (within parenthesis marks).

Figure legends

Figure legends must be mentioned with clear distinction

Tables

Tables should be submitted in separate text file.Total number of the tables will not be more than 5 and a total number of table and figure should be 6. Tables should be carefully constructed so that the data represented may be understood easily. All tables must be identified by Roman numerals in consecutive order before its heading as Table-I, Table-II etc. Every table, every column and every row should be supplied with an appropriate and self-explanatory heading. The table number and the title should be placed in a continuous heading above the data presented. Foot notes to the table may be given, if required to make it explicit, this in the body of the table by Roman superscripts in sequence.

Figures

Total number of the figures will not be more than 5 and a total number of tables and figures should be 6. If more than 6 figures and tables are required, the author must explain justification of the increased number of the tables/figures during submission and must mention in the cover letter. Please also submit figures as separate figure files (tif, jpeg, eps, gif) with 300 dpi resolution or better. Figures should be identified in consecutive order by Arabic numerals as Fig. 1, Fig. 2, Fig. 3 etc. Original drawings are preferable but photographic prints are also accepted if clear, well prepared and on glossy paper with strong contrasts.

Images

Our policy on obtaining consent for publication of pictures of patients is a subset of our general policy on patients confidentiality. If there is any chance that a patient may be identified from a photograph or other image or from its legend or accompanying text we need patient’s written consent for publication in the journal. Images-such as x rays, laparoscopic images, ultrasound images, pathology slides or images of indistinctive parts of the body – may be used without consent so long as they are anonymised by the removal of any identifying marks and are not accompanied by text that could reveal the patient’s identity through clinical or personal detail. All drawings should be made with China ink on white drawing paper.

Supplementary files

Supplementary files are optional. It could be figures or tables or data file or any documents that enhance more transparency, clarity of the research work or manuscript.

Reference format :

Standard journal article

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.List the first six authors, followed by et al. Ifthere are more than six authors, list the first six authors, followed by et al. Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

Optional: If a journal carries continuous pagination throughout a volume (as many medical journals do), omit the month and issue number.Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

Optional: Addition of a database's unique identifiers, such as the PubMed PMID, for the citation. Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveitic foveal atrophy: clinical features and associations. Arch Ophthalmol. 2009 Feb;127(2):179-86. PubMed PMID: 19204236; PubMed Central PMCID: PMC2653214. Optional: Addition of a clinical trial registration number: Trachtenberg F, Maserejian NN, Soncini JA,Hayes C, Tavares M. Does fluoride incompomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registrationnumber: NCT00065988.

Organization as author

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

Both personal authors and organization as author (list all as they appear in the byline).Vallancien G, Emberton M, Harving N, vanMoorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.

No author given

21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.

Article not in english

Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7. Norwegian. Optional: Translation of article title (MEDLINE/PubMed practice): Ellingsen AE, Wilhelmsen I. [Disease anxiety among medical students and law students].Tidsskr Nor Laegeforen. 2002 Mar 20;122(8): 785-7. Norwegian.

Volume with supplement

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

Issue with supplement

Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.

Volume with part

Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002;83(Pt 2):491-5.

Issue with part

Ahrar K, Madoff DC, Gupta S, Wallace MJ, PriceRE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol.2002;13(9 Pt 1):923-8.

Issue with no volume

Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-8. 11. No volume or issue Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.

Pagination in roman numerals

Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002;16(2):iii-v.

Type of article indicated as needed

Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy[letter]. Eur Respir J. 2002;20(1):242. Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.

Article containing retraction

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2002;63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000;61(12):909-11.

Article containing a partial retraction:

Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. J Urol. 2006 Dec;176(6Pt 1):2749. Partial retraction of: Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Sep;176(3):1040-4.

Article retracted

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000;61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002;63(2):169.

Article partially retracted:

Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction following removal of eroded synthetic mid urethral slings. J Urol. 2006 Sep;176(3):1040-4. Partial retraction in: Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Dec;176(6 Pt 1):2749.

Article republished with corrections

Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002;188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001;183(1-2):123-6.

Article with published erratum

Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical

review. Clin Ther. 2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther. 2001;23(2):309.

Article published electronically ahead of the print version

Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5.

Books and other monographs

Personal author(s)

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Editor(s), compiler(s) as author

Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New

York: McGraw-Hill; 2002.

Author(s) and editor(s)

Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

Organization(s) as author

American Occupational Therapy Association, Ad Hoc Committee on Occupational Therapy

Manpower. Occupational therapy manpower: a plan for progress. Rockville (MD): The Association; 1985 Apr. 84 p.

Chapter in a book

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Conference proceedings

Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell

Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.

Conference paper

Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic

programming. In: Foster JA, Lutton E, Miller J,Ryan C, Tettamanzi AG, editors. Genetic

programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic

Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

Scientific or technical report

Issued by funding/sponsoring agency: Yen GG (Oklahoma State University, School of Electrical and Computer Engineering, Stillwater, OK). Health monitoring on vibration signatures. Final report. Arlington (VA): Air Force Office of Scientific Research (US), Air Force Research Laboratory; 2002 Feb. Report No.:AFRLSRBLTR020123. Contract No.: F496209810049.

Issued by performing agency:

Russell ML, Goth-Goldstein R, Apte MG, Fisk WJ. Method for measuring the size distribution of airborne Rhinovirus. Berkeley (CA): Lawrence Berkeley National Laboratory, Environmental Energy Technologies Division; 2002 Jan. Report No.: LBNL49574. Contract No.: DEAC0376SF00098. Sponsored by the Department of Energy.

Dissertation

Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.

Patent

Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1. Other published material

Newspaper article

Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).

Audiovisual material

Chason KW, Sallustio S. Hospital preparedness for bioterrorism [videocassette]. Secaucus (NJ): Network for Continuing Medical Education; 2002.

Legal material

Public law: Veterans Hearing Loss Compensation Act of 2002, Pub. L. No. 107-9, 115 Stat. 11 (May 24,2001).

Unenacted bill:

Healthy Children Learn Act, S. 1012, 107th Cong., 1st Sess. (2001).

Code of federal regulations:

Cardiopulmonary Bypass Intracardiac Suction Control, 21 C.F.R. Sect. 870.4430 (2002). Hearing:Arsenic in Drinking Water: An Update on the Science, Benefits and Cost: Hearing Before the Subcomm. on  Environment, Technology and Standards of the House Comm. on Science,

107th Cong., 1st Sess. (Oct. 4, 2001).

Map

Pratt B, Flick P, Vynne C, cartographers.Biodiversity hotspots [map]. Washington:Conservation International; 2000.

Dictionary and similar references

Dorland's illustrated medical dictionary. 29thed. Philadelphia: W.B. Saunders; 2000. Filamin;675.Unpublished material

Forthcoming and preprints

(Note: NLM prefers "Forthcoming" rather than "In press" because not all items will be printed.) Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. Forthcoming 2002.Electronic material

CD-ROM

Anderson SC, Poulsen KB. Anderson's electronic atlas of hematology [CD-ROM]. Philadelphia: Lippincott Williams & Wilkins; 2002.

Journal article on the internet

Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from:

https://journals.lww.com/ajnonline/Fulltext/2002/06000/Quality_Improvement_Initiative_i

n_Nursing_Homes.31.aspx

Subscriptionrequired.Optional presentation (omits bracketed phrase

that qualifies the journal title abbreviation):Abood S. Quality improvement initiative in

nursing homes: the ANA acts in an advisory role.Am J Nurs. 2002 Jun [cited 2002 Aug12];102(6):[about 1 p.]. Available from: https://journals.lww.com/ajnonline/Fulltext/2002/06000/Quality_Improvement_Initiative_in_Nursing_Homes.31.aspx

Subscriptionrequired.Article published on the Internet ahead of the print version:See # 18. Optional formats used by NLM in MEDLINE/PubMed: Article with document number in place of traditional pagination: Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement.N Engl J Med. 2009 Jan 29;360(5):e6. PubMed PMID: 19179309. Article with a Digital Object Identifier (DOI): Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ. 2009 Jan 7;338:a2752. doi: 10.1136/bmj.a2752. PubMed PMID: 19129307; PubMed Central PMCID: PMC2615549. Article with unique publisher item identifier (pii) in place of traditional pagination or DOI: Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill. 2009 Feb 12;14(6). pii: 19119. PubMed PMID: 19215721.

Monograph on the internet

Foley KM, Gelband H, editors. Improving palliative care for cancer [Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from:

https://www.nap.edu/catalog/10149/improving -palliative-care-for-cancer.

Homepage/web site

eatright.org [Internet]. Chicago: Academy of Nutrition and Dietetics; c2016 [cited 2016 Dec27].

Available from: https://www.eatright.org/.

Part of a homepage/Web site

American Medical Association [Internet]. Chicago: The Association; c1995-2016 [cited 2016 Dec 27]. Office of International Medicine; [about 2 screens].

Available from:

https://www.ama-assn.org/about/office-international-medicine

Database on the internet

Open database: Who's Certified [Internet]. Evanston (IL): The American Board of Medical Specialists. C2000 - [cited 2001 Mar 8]. Available from: https://www.abms.org/verify-certification/

Closed database: Jablonski S. Online Multiple Congenital Anomaly/Mental Retardation (MCA/MR)

Syndromes [Internet]. Bethesda (MD): National Library of Medicine (US); c1999 [updated 2001

Nov 20; cited 2002 Aug 12].

Available from: https://www.nlm.nih.gov/archive//20061212/mesh/jablonski/syndrome_title.html

  1. Part of a database on the internet

MeSH Browser [Internet]. Bethesda (MD): U.S.National Library of Medicine; 2002 -. Meta-analysis; [cited 2017 Dec 1]; [about 1 p.].

Available from: https://www.meshb.nlm.nih.gov/record/ui?ui=D017418 MeSH Unique ID: D017418.

Blogs

Holt M. The Health Care Blog [Internet]. San Francisco: Matthew Holt. 2003 Oct - [cited

2009Feb 13]. Available from:http://thehealthcareblog.com/blog/category/matthew-holt/.

Contribution to a blog:

Mantone J. Head trauma haunts many, researchers say. 2008 Jan 29 [cited 2009 Feb 13]. In: Wall Street Journal. HEALTH BLOG [Internet]. New York: Dow Jones & Company, Inc. c2008 -. [about 1 screen]. Available from: https://blogs.wsj.com/health/2008/01/29/hea d-trauma-haunts-many-researchers-say/.

Campbell A. Diabetes and alcohol: do the two mix? (Part 2). 2008 Jan 28 [cited 2009 Feb 13].

In: Diabetes Self-Management Blog. New York: Diabetes Self-Management. [2006 Aug 14] - . 2

  1. Available from: https://www. Diabetessel fmanagement.com/blog/Amy_Campbell/Diabe

tes_and_Alcohol_Do_the_Two_Mix_Part_2

Datasets

Dataset description article:

Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, Hendrickx G, Schaffner F, Wint GR, Elyazar IR, Teng HJ, Hay SI. The global compendium of Aedes aegypti and Ae. albopictus occurrence. SciData. 2015 Jul 7 [cited 2015 Oct 23];2:150035.Available from: http://www.nature.com/articles/sdata201535 doi:10.1038/sdata.2015.35 eCollection 2015. PubMed PMID: 26175912;PubMed Central PMCID: PMC4493829. Dataset deposit record: Citing Medicine format Kraemer MUG, Sinka ME, Duda KA, Mylne A,Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W,Hendrickx G, Schaffner F, Wint GRW, Elyazar IRF,Teng H, Hay SI. The global compendium of Aedes aegypti and Ae. albopictus occurrence [dataset].2015 Jun 30 [cited 2015 Oct 23]. In: Dryad Digital Repository [Internet]. Durham (NC): Dryad. 2008Jan - . 3 files: 3.406 MB; 1.549 MB; 1.815 MB. Available from: https://datadryad.org/resource/doi:10.5061/dryad.47v3c Referenced in doi:10.7554/eLife. 08347

Dataset deposit record: Simplified format Kraemer MUG, Sinka ME, Duda KA, Mylne A,

Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel

W, Hendrickx G, Schaffner F, Wint GRW,Elyazar IRF, Teng H, Hay SI. The global compendium of Aedes aegypti and Ae. Albopictus occurrence [dataset]. 2015 Jun 30 [cited 2015

Oct 23]. Dryad Digital Repository. Available from: https://datadryad.org/resource /doi:10 .5061/dryad.47v3c Referenced in doi:10.7554/eLife.08347 Dataset repository: Citing Medicine format Dryad Digital Repository [Internet]. Durham(NC): Dryad. 2008 Jan - [cited 2014 Oct 3].

Available from: https://www.datadryad.org

Dataset repository: Simplified format Dryad Digital Repository. Durham (NC): Dryad.

[cited 2014 Oct 3]. Available from: https://www.datadryad.org/.Dataset: Citing Medicine format RxNorm [dataset on the Internet]. April 4, 2016 Full Monthly Release. Bethesda (MD): U.S. National Library of Medicine; 2016 Apr 4 [cited 2016 Apr 18]. Available from:

https://www.nlm.nih.gov/research/umls/rxnorm/docs/rxnormfiles.html

Dataset: Simplified format

RxNorm [dataset]. April 4, 2016 Full Monthly Release. 2016 Apr 4 [cited 2016 Apr 18].

Available from:  https://www.nlm.nih.gov/research/umls/rxnorm/docs/rxnormfiles.html

Software on the internet

Hayes B, Tesar B, Zurow K. OTSoft: Optimality Theory Software. Version 2.3.2 [software]. 2013

Jan 14 [cited 2015 Feb 14]. Available from: https://linguistics.ucla.edu/people/hayes/otsoft/.

Dataset: Simplified format RxNorm [dataset]. April 4, 2016 Full Monthly Release. 2016 Apr 4 [cited 2016 Apr 18]. Available from: https://www.nlm.nih.gov/ research/umls/rxnorm/docs/rxnormfiles.html Golda TG, Hough PD, Gay G. APPSPACK

(Asynchronous Parallel Pattern Search). Version 5.0.1 [software]. Sandia National Laboratories. 2007 Feb 16 [cited 2016 Apr 4; downloaded 2010 Jan 5]. Available from: https://dakota.sandia.gov/packages/hopspack.

Submission Preparation Checklist

All submissions must meet the following requirements.

  • This submission meets the requirements outlined in the Author Guidelines.
  • This submission has not been previously published, nor is it before another journal for consideration.
  • All references have been checked for accuracy and completeness.
  • All tables and figures have been numbered and labeled.
  • Permission has been obtained to publish all photos, datasets and other material provided with this submission.

Articles

Section default policy

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 25 February 2020)